|
|
ChemGenics Pharmaceuticals |
Genetically directed drug discovery focused on fungal bacterial diseases |
Acquired |
1997 |
 |
|
|
 |
Discovery, development and commercialization of prescription pain management products |
IPO |
2000 |
|
|
|
 |
Discovery, development and commercialization of druts to treat neurological diseases and disorders |
IPO |
2004 |
|
|
|
 |
Discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases. |
IPO |
2005 |
|
|
|
 |
Discovering, developing and commercializing cancer therapeutics. |
IPO |
2010 |
|
|
|
 |
Developmental biology insights for regenerative medicine therapies |
Acquired |
2000 |
 |
|
|
 |
Developing therapeutic candidates for the treatment of immune and metabolic diseases. |
IPO |
2013 |
|
|
|
 |
Developing resolvins, a novel class of therapies to treat inflammatory diseases and their complications. |
Acquired |
2011 |
.jpg) |
|
|
 |
Developing novel therapeutics to promote vascular repair. |
Acquired |
2012 |
.jpg) |
|
|
 |
Developing novel protein measurement systems based on Protien Epitope Tag technology |
Acquired |
2009 |
 |
|
|
 |
Developing new class of therapeutic compounds. |
Acquired |
2007 |
 |
|
|
 |
Developing and manufacturing revolutionary, low-cost, high-performance flow cytometers for researchers. |
Acquired |
2011 |
 |
|
|
 |
Developing small molecule therapeutics for multiple oncology and immunology-based indications |
Acquired |
2010 |
 |
|
|
 |
Developer of high-technology purification, analysis and synthesis products |
Acquired |
1998 |
 |
|
|
 |
Design, development, manufacturing, and marketing of medical devices focused on women's health |
IPO |
1996 |
|
|
|
 |
Creating novel antibiotics for serious and life-threatening multi-drug resistant infections. |
IPO |
2013 |
|
